Epinastine Hydrochloride

CAS 108929-04-0 6 current records 1 historicalSmall Molecule

Who holds supplier records for Epinastine Hydrochloride? 6 organisations hold a current record for Epinastine Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 1 organisation has only historical (inactive) DMF filings. 2 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: Italy (2), Germany (1), China (1), France (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Epinastine Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/epinastine-hydrochloride

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • 5 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Epinastine Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Epinastine Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (2)

Certificates of Suitability on the EDQM register for Epinastine Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

HolderCountryCertificateIssuedEU GMP at holder's address
WUHAN CALMLAND PHARMACEUTICALS CO., LTD. WuhanCN
CEP 2024-295 - Rev 01
Epinastine hydrochloride
May 2026Inspected Apr 2026
Croatia
BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ingelheim Am RheinDE
R1-CEP 2011-311 - Rev 01
Epinastine hydrochloride
Mar 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (1)

Organisations whose Type II DMFs for Epinastine Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 1 historical record

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Epinastine Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200491).

Chemical identity

IUPAC name
2,4-diazatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),3,7,9,11,14,16-heptaen-3-amine;hydrochloride
Canonical SMILES
C1C2C3=CC=CC=C3CC4=CC=CC=C4N2C(=N1)N.Cl
InChIKey
VKXSGUIOOQPGAF-UHFFFAOYSA-N
Synonyms
Alesion, DE-114, Elestat, Epinastine hcl, Epinastine hydrochloride, Relestat, WAL 801 CL, WAL-801CL, WAL-802-CL, CHEBI:51037, WAL 801CL, RefChem:56562

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Adrenergic Receptor Agonist; Histamine-1 Receptor Inhibitor
Mechanism of action
Adrenergic Agonists; Histamine H1 Receptor Antagonists
Physiologic effect
Decreased Histamine Release

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Epinastine Hydrochloride?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Epinastine Hydrochloride: BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (Germany), WUHAN CALMLAND PHARMACEUTICALS CO LTD (China), CHEMWERTH INC (France), ICROM SRL (Italy), Sun Pharmaceutical Industries Limited (India) and TRIFARMA SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Epinastine Hydrochloride Drug Master Files are active?

BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG (DMF 15003), WUHAN CALMLAND PHARMACEUTICALS CO LTD (DMF 40256), CHEMWERTH INC (DMF 21974), ICROM SRL (DMF 21830), Sun Pharmaceutical Industries Limited (DMF 22854) and TRIFARMA SPA (DMF 21851). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Epinastine Hydrochloride records mean?

1 organisation has only inactive Type II DMFs for Epinastine Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Epinastine Hydrochloride have a European Certificate of Suitability?

Yes. 2 organisations hold a valid CEP for Epinastine Hydrochloride on the EDQM register, including WUHAN CALMLAND PHARMACEUTICALS CO., LTD. Wuhan (CN) and BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG Ingelheim Am Rhein (DE). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Epinastine Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Epinastine Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.